Fortrea Holdings Inc. (FTRE)
$20.92-0.38%Close
BUYBULL · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.0B
- Beta
- 1.91
- P/E (TTM)
- -22.49
- Short % float
- 13.41%
- Days to cover
- 7.8
- SI change
- +0.1%
- 1W
- +0.67%
- 1M
- +20.16%
- vs SPY 1W
- +0.81%
- vs SPY 1M
- +17.65%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 35
- VALUE
- 2
- GROWTH
- 33
- GARP
- 62
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC-9.3%
REV YoY-
ROE-15.5%
EPS YoY-
ROA-3.1%
GROSS17
OP0
NET-3
[VALUATION]
P/E TTM-22.49
P/E FWD22.38
SECTOR PE20.34
INDUSTRY PE13.84
P/B3.76
P/FCF-
EV/EBITDA36.19
EV/EBIT-
PEG0.89
FCF YIELD-
RISK
INT COV-
D/E213.18
ALTMAN Z-
CURR RATIO0.96
ND/EBITDA-
BETA1.91
Company news
FAQ
- What is LOPJLB’s current signal on FTRE?
- LOPJLB’s latest quantitative signal on Fortrea Holdings Inc. (FTRE) is BUY in a BULL regime. Signals are updated daily.
- What market regime is FTRE in?
- Fortrea Holdings Inc. (FTRE) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Fortrea Holdings Inc. (FTRE) do?
- Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development…